Seattle, WA34 Active Studies

Interstitial Cystitis Clinical Trials in Seattle, WA

Find 34 actively recruiting interstitial cystitis clinical trials in Seattle, WA. Connect with local research sites and explore new treatment options.

34
Active Trials
18
Sponsors
6,702
Enrolling

Recruiting Interstitial Cystitis Studies in Seattle

About Interstitial Cystitis Clinical Trials in Seattle

Interstitial cystitis/bladder pain syndrome is a chronic condition causing bladder pressure, bladder pain, and sometimes pelvic pain. It primarily affects women and can significantly impact quality of life. Treatment includes dietary changes, bladder instillations, oral medications, and neuromodulation.

There are currently 34 interstitial cystitis clinical trials recruiting participants in Seattle, WA. These studies are seeking a combined 6,702 participants. Research is being sponsored by Fred Hutchinson Cancer Center, Johns Hopkins University, University of Washington and 15 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Interstitial Cystitis Clinical Trials in Seattle — FAQ

Are there interstitial cystitis clinical trials in Seattle?

Yes, there are 34 interstitial cystitis clinical trials currently recruiting in Seattle, WA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Seattle?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Seattle research site will contact you about next steps.

Are clinical trials in Seattle free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Seattle studies also compensate for your time and travel.

What interstitial cystitis treatments are being tested?

The 34 active trials in Seattle are testing new therapies including novel drugs, biologics, and treatment approaches for interstitial cystitis.

Data updated July 16, 2026 from ClinicalTrials.gov